Log in
广发证券-国药股份(600511)精麻业务利润占比有望超50%，业绩加速增长-230511
English body is not available for this report yet; showing the Chinese version. View in Chinese
常见问题
- 这份报告主要研究什么？
- 《广发证券-国药股份(600511)精麻业务利润占比有望超50%，业绩加…》主要讨论：国药股份：卡位优势显著的麻精特药分销龙头。公司是国药控股的商业平台，以“药械流通”为主业，以北京区域医疗机构直销为核心，并以精麻业务为特色，同时覆盖全国药品分销、医药零售、医药工业等业务。预计 20…
- 报告来自哪个机构？何时发布？
- 来源机构：广发证券，篇幅约 25 页。
Copyright notice
This report is aggregated from publicly available internet sources. Copyright belongs to the original authors or rights holders. If you are a rights holder and believe content on this platform infringes your rights, please email copyright@ruishubaogao.com . We will remove the content promptly after verification.